Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01233401 · ClinicalTrials.gov registry record
Tdap Vaccination for Infant Caregivers
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 102
- Enrollment target
NCT01233401: Completed study, sponsored by Yale University.
NCT01233401 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01233401 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-06 |
What the finished NCT01233401 record still lists
NCT01233401 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT01233401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01233401 about?
NCT01233401 is a clinical study titled "Tdap Vaccination for Infant Caregivers". This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.
What is the current status of trial NCT01233401?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2010-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01233401?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT01233401?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia